Moreover, Anderson et al. demonstrated that SEMA4A is essential for MM cell survival [11], suggesting that it is less likely to be lost through genetic deletions, a common mechanism of acquiring therapy resistance in MM. This evidence concerns the gene SEMA4A and Miyoshi myopathy.